BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Acuity Pharmaceuticals (Merger with Froptix and eXegenics to Create Opko Corporation) 

Press releases archived for reference only.
3701 Market Street
Philadelphia  Pennsylvania  19104  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye 3/27/2007 1:07:26 PM    More...
Acuity Pharmaceuticals Appoints Denis O'Shaughnessy Senior Vice President Of Clinical Development 10/24/2006 11:09:14 AM    More...
Acuity Pharmaceuticals Reports Positive Phase II Results For Bevasiranib In Wet AMD 9/11/2006 8:15:38 AM    More...
Acuity Pharmaceuticals And Pathogenics Inc. Announce Preclinical Data Demonstrating Utility Of NCT In Viral Conjunctivitis 8/23/2006 9:08:26 AM    More...
Acuity Pharmaceuticals Reports Positive Initial Phase II Results For Bevasiranib (Cand5) In Wet AMD 6/1/2006 11:02:33 AM    More...
ZaBeCor Pharmaceutical Co. Licenses Its Anti-Inflammatory siRNA Technology To Acuity Pharmaceuticals For Ophthalmic Uses 4/28/2006 10:41:51 AM    More...
Acuity Pharmaceuticals Continues Pipeline Expansion By Licensing A Novel Broad Spectrum Anti-Infective For Ophthalmic Use 4/20/2006 11:22:32 AM    More...
Acuity Pharmaceuticals Completes Patient Enrollment In Phase II Trial In Wet AMD And Initiates New Trial In Diabetic Macular Edema 2/2/2006 10:39:19 AM    More...
Acuity Pharmaceuticals To Present At Rodman & Renshaw Healthcare Conference 11/4/2005 12:59:46 PM    More...
Acuity Pharmaceuticals Initiates Phase II Trial Of Cand5 In Wet AMD Following Successful Completion Of Phase I 10/19/2005 5:13:21 PM    More...
123